BridgeBio Pharma, Inc. (BBIO)
73.15
-1.30
(-1.75%)
USD |
NASDAQ |
Apr 02, 16:00
73.17
+0.02
(+0.03%)
After-Hours: 20:00
BridgeBio Pharma Accounts Receivable (Annual) : 139.44M for Dec. 31, 2025
Accounts Receivable (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Annual) Benchmarks
| Pfizer Inc. | 11.87B |
| Insmed, Inc. | 140.86M |
| Mirum Pharmaceuticals, Inc. | 123.33M |
| Supernus Pharmaceuticals, Inc. | 187.80M |
| Apellis Pharmaceuticals, Inc. | 366.22M |